ITGAX and neoplasm: Specifically, IL-2/CD40 reduced expression of several regulatory molecules (CD39, A2AR, A2BR, PD-L1, ICOS, and/or IL-10) on young tumor-infiltrating CD11c+ cells and CD4+ T cells, suggesting reduced suppressive activity.